Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Reproductive Sciences (Thousand Oaks, Calif.)|August 5, 2016
Testosterone for Poor Ovarian Responders: Lessons From Ovarian PhysiologyNikolaos P Polyzos, Susan R Davis, Panagiotis Drakopoulos, et al.
Human Reproduction (Oxford, England)|December 29, 2025
The impact of transdermal testosterone treatment on quality of life in women with diminished ovarian reserve: secondary analysis of a randomized controlled trialSebastian J Leathersich, Susan R Davis, Sandra García Martínez, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|July 29, 2020
Testosterone for Poor Ovarian Responders: Lessons From Ovarian PhysiologyNikolaos P Polyzos, Susan R Davis, Panagiotis Drakopoulos, et al.
Nature Communications|February 12, 2026
Transdermal testosterone gel vs placebo in women with diminished ovarian reserve prior to in vitro fertilization: a randomized, clinical trialNikolaos P Polyzos, Sebastian J Leathersich, Francisca Martínez, et al.
Menopause (New York, N.Y.)|August 26, 2006
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 StudyJan L Shifren, Susan R Davis, Michele Moreau, et al.
Menopause (New York, N.Y.)|May 14, 2024
Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortiumVincent S Paramanandam, Sarah Lensen, Michaela Gabes, et al.
Journal of Women'S Health (2002)|April 2, 2021
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in WomenSharon J Parish, James A Simon, Susan R Davis, et al.
Climacteric : the Journal of the International Menopause Society|April 1, 2021
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in WomenSharon J Parish, James A Simon, Susan R Davis, et al.
The Journal of Sexual Medicine|April 5, 2021
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in WomenSharon J Parish, James A Simon, Susan R Davis, et al.
Menopause (New York, N.Y.)|June 6, 2018
The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel reviewJames A Simon, Irwin Goldstein, Noel N Kim, et al.
Pageof 27